Succinic Semialdehyde Dehydrogenase Deficiency: An Update
Open Access
- 18 February 2020
- Vol. 9 (2), 477
- https://doi.org/10.3390/cells9020477
Abstract
Succinic semialdehyde dehydrogenase deficiency (SSADH-D) is a genetic disorder that results from the aberrant metabolism of the neurotransmitter γ-amino butyric acid (GABA). The disease is caused by impaired activity of the mitochondrial enzyme succinic semialdehyde dehydrogenase. SSADH-D manifests as varying degrees of mental retardation, autism, ataxia, and epileptic seizures, but the clinical picture is highly heterogeneous. So far, there is no approved curative therapy for this disease. In this review, we briefly summarize the molecular genetics of SSADH-D, the past and ongoing clinical trials, and the emerging features of the molecular pathogenesis, including redox imbalance and mitochondrial dysfunction. The main aim of this review is to discuss the potential of further therapy approaches that have so far not been tested in SSADH-D, such as pharmacological chaperones, read-through drugs, and gene therapy. Special attention will also be paid to elucidating the role of patient advocacy organizations in facilitating research and in the communication between researchers and patients.This publication has 144 references indexed in Scilit:
- Autophagy modulation as a potential therapeutic target for diverse diseasesNature Reviews Drug Discovery, 2012
- Therapeutic Efficacy of Magnesium Valproate in Succinic Semialdehyde Dehydrogenase DeficiencyJIMD Reports, 2012
- Neuropathology in Succinic Semialdehyde Dehydrogenase DeficiencyPediatric Neurology, 2010
- Systematic Evaluation of AAV Vectors for Liver directed Gene Transfer in Murine ModelsMolecular Therapy, 2010
- Brain gangliosides in axon–myelin stability and axon regenerationFEBS Letters, 2009
- The effects of a ketogenic diet on ATP concentrations and the number of hippocampal mitochondria in Aldh5a1−/− miceBiochimica et Biophysica Acta (BBA) - General Subjects, 2009
- Redox-switch modulation of human SSADH by dynamic catalytic loopThe EMBO Journal, 2009
- Succinic semialdehyde dehydrogenase deficiency: Lessons from mice and menJournal of Inherited Metabolic Disease, 2009
- A ketogenic diet rescues the murine succinic semialdehyde dehydrogenase deficient phenotypeExperimental Neurology, 2008
- Lipid abnormalities in succinate semialdehyde dehydrogenase (Aldh5a1−/−) deficient mouse brain provide additional evidence for myelin alterationsBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2007